Senhwa Biosciences Announces Positive Clinical Data from Phase 1/Expansion Trial of Silmitasertib (CX-4945) in the Treatment of Basal Cell Carcinoma Basal Cell Carcinoma CSR Highlights CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months… CISION PRNewswireApril 2, 2025
Over 2/3 of Companies Surveyed Believe that Reciprocal Tariffs Present Greater Concerns for Business Survey by The American Chamber of Commerce in Singapore (AmChamSG) Reveals a… CISION PRNewswireApril 2, 2025
Press ReleaseJiangxi-GBA Economic Cooperation Promotion Held Successfully SHENZHEN, China, April 2, 2025 /PRNewswire/ — A report from Jiangxi International Communication… CISION PRNewswireApril 2, 2025
Group-IB Recognized with the 2025 Frost & Sullivan Global Technology Innovation Leadership Award Innovative Approach to Cybersecurity Earns Group-IB Industry Recognition SAN ANTONIO, April 2,… CISION PRNewswireApril 2, 2025
Splunk Advances OpenTelemetry Experience with New Innovations to Boost Digital Resilience New observability innovations empower organizations to apply OpenTelemetry to large-scale environments with complete… CISION PRNewswireApril 2, 2025
Ponsse Greasing System – new solutions for forest machines chain lubrication VIEREMÄ, Finland, April 2, 2025 /PRNewswire/ — The PONSSE Greasing System is a new… CISION PRNewswireApril 2, 2025
Press ReleaseGlobe is first telco to join UN-led DISHA initiative for disaster response MANILA, Philippines, April 2, 2025 /PRNewswire/ — In a landmark pro bono… CISION PRNewswireApril 2, 2025
Press ReleaseFutu Trustee Is Recognized as "Hong Kong Best Trust Administrator" HONG KONG, April 2, 2025 /PRNewswire/ — Futu Trustee was honoured as… CISION PRNewswireApril 2, 2025